טוען...
Alpha-synuclein contributes to malignant progression of human meningioma via the Akt/mTOR pathway
BACKGROUND: The aim of this study is to explore the expression of alpha-synuclein (α-synuclein) in benign, atypical, and anaplastic meningiomas and determine its role in the malignant progression of meningiomas. METHODS: Expression of α-synuclein was measured in 44 meningioma samples by real-time PC...
שמור ב:
| הוצא לאור ב: | Cancer Cell Int |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5109801/ https://ncbi.nlm.nih.gov/pubmed/27895530 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-016-0361-y |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|